Dr Reddys Laboratories Share Price Today - Live Blog for August 07, 2025

With a remarkable 0.05% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,202.40. Notably, this stock has a Price-to-Earnings (PE) ratio of 17.5900, while the industry's PE ratio is 34.1355.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.12%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,202.90 per share.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.21%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,201.00 per share.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.06% recently. As of now, this stock is actively trading at a current market price of ₹1,195.35 per share, attracting attention from investors.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.06%, reaching the current market price of ₹1,195.35. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.24% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,194.40 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Following a noteworthy 0.07% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,189.90. When it comes to valuation, this stock has a PE ratio of 17.5900, with the industry PE ratio at 34.1355.

Demonstrating a commendable 0.07% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,189.90. In terms of valuation, the stock maintains a PE ratio of 17.5900, while the industry PE ratio stands at 34.1355.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.03% increase and currently trading at ₹1,190.40 per share. This upward trajectory is turning heads in the market.

After a notable 0.03% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,190.40. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.16%, reaching the current market price of ₹1,190.25. This development underscores the stock's growing popularity.

Dr Reddys Laboratories Ltd's shares experienced a 0.05% uptick, and they are currently valued at ₹1,188.40, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd's shares experienced a 0.25% uptick, and they are currently valued at ₹1,188.35, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.01% uptick in its share price. As a result, it's now actively trading at ₹1,185.00 per share, making it an attractive option for investors.

With a -0.06% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,188.50. This development raises questions about the factors behind the decline. The stock's PE ratio is 17.5900, while the industry PE is 34.1355.

Dr Reddys Laboratories Ltd share price has declined by -0.06%, and it's currently trading at ₹1,188.50. The stock maintains a PE of 17.5900, while the industry PE is 34.1355, prompting discussions about its valuation.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.04% increase and currently trading at ₹1,186.90 per share. Investors are taking notice of this upward momentum.

Dr Reddys Laboratories Ltd stock price decreased by -0.11%, with the current market value at ₹1,186.45 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.03% drop, and it's now trading at ₹1,188.00 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

After a notable 0.11% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,188.00. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd stock price decreased by -0.37%, with the current market value at ₹1,187.20 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.19%, with its current market value per share resting at ₹1,191.00. This development highlights the stock's appeal to investors.

Dr Reddys Laboratories Ltd's share price has fallen by -0.20%, a situation worth noting. At present, the stock is trading at ₹1,191.25. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 17.5900, while the industry PE ratio is 34.1355.

Dr Reddys Laboratories Ltd stock price decreased by -0.34%, with the current market value at ₹1,193.40 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.15% increase. Presently, it is actively trading at ₹1,195.80.

Dr Reddys Laboratories Ltd observed a -1.30% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,182.40. The stock has a PE ratio of 17.5900, an ROE of 16.8559% and a debt to equity ratio of 0.1394.